Chief Executive Officer

Dx4Life; Lunds kommun; On-site; SEK 3,000,000 - 6,000,000; Full time

Benefits offered by this job

Stock option program

Competitive compensation package

Dynamic Medicon Village environment

Job summary

Dx4Life, a pioneering medical diagnostics company in Lund, Sweden, seeks a commercially driven CEO to lead growth and overall development.

You will own strategy, P&L, and stakeholder relationships, drive product commercialization, expand Nordic/European markets, and build an organization capable of sustainable long-term growth.

Qualifications

• Minimum 10+ years in executive sales/marketing and leadership roles.
• Proven track record of initiating, scaling, and leading product commercialization and launches.
• Experience leading life sciences companies with R&D and production capabilities.

Responsibilities

• Provide visionary leadership and set strategic direction with budget and personnel accountability.
• Own full P&L responsibility and represent the company to the Board.
• Develop and nurture relationships with clients and partners to support product development and market launch.
• Drive business development to expand market reach and revenue streams.
• Collaborate with Board and shareholders to refine strategic priorities.
• Ensure a scalable cost structure aligned with development stage.

Skills

Executive leadership

Sales & marketing

General management

Business development

Market access

Negotiation

Strategic mindset

Communication

Entrepreneurial spirit

Travel readiness

Education

Master's degree (MSc or MBA)

Job description

You are driven by building companies with real impact — where commercial success goes hand in hand with the opportunity to change people’s lives. An exciting opportunity is now available to lead a pioneering medical diagnostics company into an era of commercial growth.

Dx4Life has developed a groundbreaking genetic rapid-testing platform that enables personalized hormone treatment selection prior to IVF. By choosing the right treatment, the chances of pregnancy are significantly increased for couples struggling with infertility. With its first product entering the commercial phase in 2026, the company is in a highly exciting phase.

Dx4Life is now seeking a commercially driven CEO who wants to take overall responsibility for the company’s continued development, growth, and commercialization. The role is ideal for someone who combines leadership with proven commercial experience within the life sciences industry. You are motivated by turning vision into commercial reality, identifying new business opportunities, and building an organization capable of achieving sustainable long-term growth.

Key areas of responsibilities

• Provide visionary leadership and execute the strategic direction, with full accountability for budget and personnel.
• Full profit and loss (P&L) responsibility and represent the company in all matters related to the Board.
• Develop and nurture relationships with new clients and partners to support product development and successful market launch of the first product.
• Drive continuous business development initiatives to expand market reach and revenue streams.
• Work closely with the Board and active shareholders to refine and implement the company’s strategic priorities.
• At all times ensure an efficient and scalable cost structure aligned with the company’s strategic development stage.

Candidate Profile

The ideal candidate has the following experience:

• A strong executive background with proven leadership experience in the life sciences industry.
• A successful track record of initiating, scaling, and leading product commercialization and product launches.
• At least 10 years of experience in sales and marketing roles.
• General management and leadership experience, preferably from high-growth environments.
• Experience leading companies with in-house R&D capabilities and production.
• Demonstrated business development experience across Nordic and European markets.
• Experience in working with distributors, licensees, and strategic partners.
• Market access experience is important.
• Experience from working in a start-up or small company is a plus.

Leadership and personal characteristics

The successful candidate will possess the following characters:

• A positive mindset and a generally cheerful personality.
• Unpretentious and willing to do what is needed in a start-up company.
• A natural Leader with executive presence and the ability to inspire confidence.
• Excellent communication skills, both verbal and written.
• Excellent business negotiation skills.
• A strategic mindset combined with hands‑on and operational leadership approach.
• Ability to inspire and motivate high-performing colleagues while creating a productive teamwork environment.
• Commercially minded and international commercial experience.
• Business Acumen and ability to drive and manage new deals – good business developer.
• Ability and will to drive growth.
• Entrepreneurial spirit and ability to thrive in fast-paced, evolving environments.
• Ability to show results, deliver on time and communicate results internally and externally.
• Deep understanding of the CEO’s role and relationship with the Board and its governance role.

Language

Fluent in verbal and written English.

Education

University Degree e.g. Master of Science or Master of Business Administration or corresponding relevant education.

Additional information

The role is located in Lund, and the candidate needs to have a permanent base in the Skåne region. The candidate should be prepared for at least 50 travel days per year as part of the role.

What we offer

• The opportunity to be part of an extremely exciting company with tremendous potential, from the start-up phase into scale-up.
• A competitive salary and a qualified stock option program at Sr. management level.
• A dynamic working environment at the vibrant Medicon Village in Lund, where the company is headquartered and has its production facility.

Dx4Life

An increasing number of couples around the world are struggling with infertility, leading to a growing demand for IVF treatment (in vitro fertilization). However, IVF is neither simple nor straightforward. The key to improving outcomes is to provide each individual with the right hormone treatment prior to IVF.

The challenge has been the lack of a clinically useful biomarker capable of reliably determining which hormone treatment should be used in each individual case.

Through her research, founder and Professor Yvonne Lundberg Giwercman discovered a novel biomarker that can reliably determine which hormone treatment each patient should receive — thereby dramatically improving the chances of pregnancy. This discovery has paved the way for a simple test that can be used directly at fertility clinics. The company was established in 2024 and is now ready for full commercialization.